Twice daily administration of beclomethasone dipropionate dry-powder in the management of chronic asthma.
Asian Pac J Allergy Immunol
;
1986 Dec; 4(2): 129-32
Artículo
en Inglés
| IMSEAR
| ID: sea-36815
ABSTRACT
In a double-blind cross-over study beclomethasone dipropionate inhaled as a dry-powder in a dose of 400 micrograms twice daily was compared with a conventional aerosol in a dose of 100 micrograms four times daily in 16 outpatients with chronic asthma. Each of the 2 treatments lasted for 4 weeks. There was no significant difference with respect to daily peak expiratory flow rates, symptom scores, bronchodilator usages and other lung function measurements between the 2 treatments. Tetracosactrin tests were within normal limits and no clinical oral candidiasis was observed throughout the study. In conclusion, beclomethasone dipropionate dry-power given twice daily was effective for the control of asthma and could be recommended for patients with poor drug compliance.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Asma
/
Administración por Inhalación
/
Humanos
/
Beclometasona
/
Esquema de Medicación
/
Método Doble Ciego
/
Ensayos Clínicos como Asunto
/
Mediciones del Volumen Pulmonar
Tipo de estudio:
Ensayo Clínico Controlado
Idioma:
Inglés
Revista:
Asian Pac J Allergy Immunol
Año:
1986
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS